NEXTCURE
Live / Registered — Registered (as of 06 Sept 2022)
What this means for you
Registered since 06 Sept 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88277082
- Registration number
- 6839737
- Mark type
- Stylized text
- Filed
- 25 Jan 2019
- Published for opposition
- 28 May 2019
- Registered
- 06 Sept 2022
- Attorney of record
- Dr. Judy Jarecki-Black
Goods and services
- Class 042 — Scientific and technological services: Research and development in the field of cancer and other diseases and medical conditions; research and development in the field of immunotherapy-based biologics for cancer and other diseases and medical conditions
Owner
- NextCure, Inc., Beltsville, MD, US
- NextCure, Inc., Beltsville, MD, US
- NextCure, Inc., Beltsville, MD, US
Prosecution history
- 23 Oct 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Oct 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Oct 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 Sept 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Sept 2022 — REGISTERED-PRINCIPAL REGISTER
- 04 Aug 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Aug 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Aug 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Jul 2022 — USE AMENDMENT FILED
- 22 Jul 2022 — TEAS STATEMENT OF USE RECEIVED
- 28 Jan 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jan 2022 — ASSIGNED TO EXAMINER
- 27 Jan 2022 — SOU EXTENSION 5 GRANTED
- 19 Jan 2022 — SOU EXTENSION 5 FILED
- 27 Jan 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL